pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,060 catalysts · 3,085 8k filing · 576 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage · 89 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 56 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-10×clear all
type
  • 8k filing3,085
  • earnings576
  • phase 2 completion172
  • grant138
  • drug shortage133
  • approval89
  • phase 1 completion73
  • phase 2 initiation62
  • phase 1 initiation40
  • recall37
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 13, 2026

    50
    ›Apr 13, 2026approval121d agoFILSPARI (SPARSENTAN) — FDA approvalsparsentan

    Sponsor: TRAVERE. Form: TABLET. Route: ORAL

    full page →sparsentan →fda approvals ↗
    ›Apr 13, 2026grant121d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Immunogenicity and Safety of High-Dose vs. Standard-Dose Influenza Vaccines A...

    AI grant. $887,964. PI: NATASHA Bassam HALASA

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Niche Trajectory Analysis of Spatial Omics Data

    HG grant. $2,583,834. PI: Guo-Cheng Yuan

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoFRED HUTCHINSON CANCER CENTER — AAV-delivered meganucleases for durable control of genital HSV disease

    AI grant. $232,558. PI: KEITH R JEROME

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoUNIV OF NORTH CAROLINA CHAPEL HILL — RNA Ribosylation's Role in Viral RNA Biology and Innate Immunity

    AI grant. $229,714. PI: Mark T Heise

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoCINCINNATI CHILDRENS HOSP MED CTR — Phenotype-Genotype Relationships in Tuberous Sclerosis

    NS grant. $441,375. PI: Steve C Danzer

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoJOSLIN DIABETES CENTER — Targeting Renalase for early stage T1D treatment

    DK grant. $826,321. PI: Accalia Fu

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoSTANFORD UNIVERSITY — Restoring Key Functions to the Industrialized Gut MicrobiomeStanford University

    AT grant. $787,346. PI: Eric C Martens

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoYALE UNIVERSITY — Deciphering Residual Malaria Mechanisms in the Peruvian Amazon to Inform Nove...

    AI grant. $580,306. PI: DIONICIA Baziliza GAMBOA VILELA

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoUNIVERSITY OF VERMONT & ST AGRIC COLLEGE — An Integrated Image-Enabled Computational Model for Lung Cancer Intratumoral ...

    CA grant. $595,012. PI: Charles Matthew Kinsey

    full page →nih reporter ↗
    ›Apr 13, 2026grant121d agoUNIVERSITY OF CINCINNATI — Consequences of mast cell activation and complement dysregulation in eosinoph...

    AI grant. $207,995. PI: Simin Zhang

    full page →nih reporter ↗
    ›04/14/2026recall120d agoGood Brain Tonic recall: Food & Beverages, Foodborne Illness, Carbonated Soft Drinks

    Good Brain Tonic 16 oz & 32 oz

    full page →fda recalls ↗
    ›Apr 14, 2026approval120d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

    Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

    full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗
    ›Apr 14, 2026approval120d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

    Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

    full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗
    ›Apr 14, 2026approval120d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

    Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

    full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗
    ›Apr 14, 2026approval120d agoDANZITEN (NILOTINIB TARTRATE) — FDA approvalDANZITEN

    Sponsor: AZURITY. Form: TABLET. Route: ORAL

    full page →DANZITEN →fda approvals ↗
    ›Apr 14, 2026approval120d agoSONAZINE (CHLORPROMAZINE HYDROCHLORIDE) — FDA approvalSaptalis Pharmaceuticals LLC

    Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2026approval120d agoRYTELO (IMETELSTAT SODIUM) — FDA approvalimetelstat sodium

    Sponsor: GERON. Form: POWDER. Route: INTRAVENOUS

    full page →imetelstat sodium →fda approvals ↗
    ›Apr 14, 2026approval120d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2026approval120d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Apr 14, 2026approval120d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Apr 14, 2026approval120d agoCANAGLIFLOZIN — FDA approvalCANAGLIFLOZIN

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →CANAGLIFLOZIN →fda approvals ↗
    ›Apr 14, 2026approval120d agoLACTULOSE — FDA approvalCUMBERLAND PHARMACEUTICALS INC

    Sponsor: CUMBERLAND PHARMS. Form: FOR SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2026approval120d agoABREVA (DOCOSANOL) — FDA approvalPL Developments Copiague LLC

    Sponsor: HALEON US HOLDINGS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Apr 14, 2026approval120d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2026approval120d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2026grant120d agoUNIVERSITY OF KANSAS MEDICAL CENTER — 25th Annual Midwest DNA Repair SymposiumUniversity of Kansas Medical Center

    ES grant. $15,000. PI: Ryan P Barnes

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Stent-based sensor system for continuous monitoring of mechanical biomarkers ...

    EB grant. $143,201. PI: Robert Herbert

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection ...

    AI grant. $1,106,984. PI: Soumya Rahima Benhabbour

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Pollutant-adsorbed nanoplastics (PANs): the influence of physicochemical prop...

    ES grant. $765,348. PI: Randy Carney

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoWADSWORTH CENTER — Mapping the determinants of bedaquiline resistance in Mycobacterium tuberculosis

    AI grant. $403,756. PI: Joseph Thomas Wade

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoUNIVERSITY OF CENTRAL OKLAHOMA — PRAISE (Pressure Relief Assessment Information System): A Paradigm-shifting M...

    EB grant. $381,392. PI: Jicheng Fu

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoLEHIGH UNIVERSITY — Creating protease-responsive hydrogels to generate cell-specific niches withi...

    EB grant. $616,375. PI: Eugene Thomas Pashuck

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoUNIVERSITY OF VIRGINIA — Preserving lung integrity and harnessing inflammation to treat vesicant-induc...University of Virginia

    ES grant. $1,460,280. PI: Chuanxi Cai

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoUNIVERSITY OF PENNSYLVANIA — Impact of Mechanical Circulatory Support and Microbiome Change on Outcomes in...University of Pennsylvania

    AI grant. $196,020. PI: Alyssa K Mezochow

    full page →nih reporter ↗
    ›Apr 14, 2026grant120d agoAMERICAN SOCIETY OF PREVENTIVE ONCOLOGY, INC. — 2026 Annual Conference Grant: American Society of Preventive Oncology

    CA grant. $40,000. PI: Michael E. Scheurer

    full page →nih reporter ↗
    ›Apr 15, 2026approval119d agoGLYCEROL PHENYLBUTYRATE — FDA approvalLupin Ltd

    Sponsor: TEVA PHARMS INC. Form: LIQUID. Route: ORAL

    full page →fda approvals ↗
    ›Apr 15, 2026approval119d agoDIACOMIT (STIRIPENTOL) — FDA approvalstiripentol

    Sponsor: BIOCODEX SA. Form: CAPSULE. Route: ORAL

    full page →stiripentol →fda approvals ↗
    ›Apr 15, 2026approval119d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 15, 2026approval119d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Apr 15, 2026approval119d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 15, 2026approval119d agoMETHOTREXATE SODIUM — FDA approvalMaxtrex

    Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

    full page →Maxtrex →fda approvals ↗
    ›Apr 15, 2026approval119d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 15, 2026approval119d agoWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvaleplontersen sodium

    Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →eplontersen sodium →fda approvals ↗
    ›Apr 15, 2026approval119d agoGLYCEROL PHENYLBUTYRATE — FDA approvalGLYCEROL PHENYLBUTYRATE

    Sponsor: AUROBINDO PHARMA. Form: LIQUID

    full page →GLYCEROL PHENYLBUTYRATE →fda approvals ↗
    ›Apr 15, 2026approval119d agoRAMELTEON — FDA approvalRAMELTEON

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →RAMELTEON →fda approvals ↗
    ›Apr 15, 2026approval119d agoALENDRONATE SODIUM — FDA approvalOrganon & Co.

    Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 15, 2026approval119d agoSODIUM BICARBONATE — FDA approvalSODIUM BICARBONATE

    Sponsor: ASPIRO. Form: SOLUTION. Route: INTRAVENOUS

    full page →SODIUM BICARBONATE →fda approvals ↗
    ›Apr 15, 2026approval119d agoGLYCEROL PHENYLBUTYRATE — FDA approvalGLYCEROL PHENYLBUTYRATE

    Sponsor: MSN. Form: LIQUID. Route: ORAL

    full page →GLYCEROL PHENYLBUTYRATE →fda approvals ↗
    ›Apr 15, 2026approval119d agoDEXTROMETHORPHAN POLISTIREX — FDA approvalDEXTROMETHORPHAN POLISTIREX

    Sponsor: AUROBINDO PHARMA LTD. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →DEXTROMETHORPHAN POLISTIREX →fda approvals ↗
    ← prev
    page 3 of 82
    next →
    $TVTX60.89-0.70%
    $AZN161.91+0.30%
    $GERN1.48000.00%
    $RDY12.15-0.57%
    $AMRX17.88-1.43%
    $CPIX7.7900-0.13%
    $JNJ261.81+0.99%
    $OGN13.62+0.15%
    $RDHL0.7390+6.64%